- Trials with a EudraCT protocol (501)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (28)
501 result(s) found for: Inflammatory Bowel Disease.
Displaying page 1 of 26.
EudraCT Number: 2014-003942-28 | Sponsor Protocol Number: MLN0002-3023 | Start Date*: 2016-05-29 | |||||||||||||||||||||
Sponsor Name:Takeda Development Centre Europe, Ltd. | |||||||||||||||||||||||
Full Title: Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Vedolizumab IV for the Treatment of Primary Sclerosing Cholangitis, With Underlying... | |||||||||||||||||||||||
Medical condition: Primary Sclerosing Cholangitis (PSC) Inflammatory Bowel Disease (IBD) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) BE (Prematurely Ended) GB (Completed) HU (Prematurely Ended) SE (Prematurely Ended) DE (Prematurely Ended) CZ (Completed) AT (Prematurely Ended) PL (Prematurely Ended) FR (Completed) IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000916-25 | Sponsor Protocol Number: GIU-5-ASA1.2 MMx-01-03 | Start Date*: 2004-09-28 | |||||||||||
Sponsor Name:GIULIANI | |||||||||||||
Full Title: A PHASE III PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUPS, STUDY, TO ASSESS THE EFFECT OF 5-ASA MMx 1.2 g Tablets IN MAINTENANCE OF REMISSION OF LEFT-SIDED ULCERATIVE COLITIS | |||||||||||||
Medical condition: TREATMENT OF ULCERATIVE COLITIS IN ACTIVE PHASE AND IN THE MAINTENANCE OF CLINICAL REMISSION | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005414-20 | Sponsor Protocol Number: 14/05 | Start Date*: 2006-03-06 | |||||||||||
Sponsor Name:ISTITUTO PER L INFANZIA BURLO GAROFOLO | |||||||||||||
Full Title: Randomized controlled double-blind Vs. placebo multicentre study on the safety and effectiveness of thalidomide in the treatment of refractory Crohn s disease and ulcerative colitis. | |||||||||||||
Medical condition: Inflammatory Bowel Disease Crohn Disease, Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004162-13 | Sponsor Protocol Number: SAE-13/IBD | Start Date*: 2007-02-27 | |||||||||||
Sponsor Name:Charité Universitätsmedizin, Campus Charité Mitte | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled phase II pilot study of the impact of mesalazine enemas on the mucosal gut flora in patients with inflammatory bowel disease | |||||||||||||
Medical condition: Active inflammatory bowel disease, i.e. either left-sided ulcerative colitis or Crohn´s Disease (Colon) with signs of inflammation within 40 cm ab ano. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010921-38 | Sponsor Protocol Number: MDL_2009_27155 | Start Date*: 2009-09-08 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis: A Double-blind, Randomized Placebo-controlled Pilot Study | |||||||||||||
Medical condition: Ulcerative Colitis and the risk of developing colorectal cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001410-10 | Sponsor Protocol Number: GIS-SUSANTI-TNF-2015 | Start Date*: 2016-06-22 | |||||||||||
Sponsor Name:Fundación de Investigación Biomédica Hospital Universitario de la Princesa | |||||||||||||
Full Title: Anti-TNF discontinuation in patients with inflammatory bowel disease: Multicentre, prospective, randomized clinical trial and economic evaluation | |||||||||||||
Medical condition: Inflammatory bowel disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003220-32 | Sponsor Protocol Number: EpicStudy | Start Date*: 2022-01-18 | |||||||||||
Sponsor Name:IRCCS MATERNO INFANTILE BURLO GAROFOLO | |||||||||||||
Full Title: Impact of early proactive therapeutic drug monitoring on the durability and efficacy of infliximab therapy in pediatric inflammatory bowel disease: a multicenter open-label randomized-control trial. | |||||||||||||
Medical condition: Pediatric Inflammatory Bowel Disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001546-33 | Sponsor Protocol Number: RHMMED1526 | Start Date*: 2018-07-11 | |||||||||||
Sponsor Name:University Southampton Hospital NHS Foundation Trust | |||||||||||||
Full Title: IBD Biosimilar to Biosimilar Infliximab Switching Study | |||||||||||||
Medical condition: Inflammatory Bowel Disease in particular Crohn's Disease and Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005192-89 | Sponsor Protocol Number: C1231001 | Start Date*: 2015-04-21 | |||||||||||
Sponsor Name:Hospira UK Ltd. | |||||||||||||
Full Title: Post-Marketing Observational Cohort Study of Patients with Inflammatory Bowel Disease (IBD) Treated with CT-P13 in Usual Clinical Practice (CONNECT-IBD) | |||||||||||||
Medical condition: Inflamatory Bowel Disease (IBD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003662-40 | Sponsor Protocol Number: UKER-AMGEVITA-CED-NOVO-01 | Start Date*: 2019-12-18 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: Prospective, open-label, single-arm, single-center phase IV clinical trial to evaluate efficacy and safety of the adalimumab biosimilar Amgevita in subjects with moderate to severe active chronic i... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003283-78 | Sponsor Protocol Number: GED-0507-01-11 | Start Date*: 2012-01-09 | |||||||||||
Sponsor Name:GIULIANI | |||||||||||||
Full Title: A PROOF-OF-CONCEPT CLINICAL STUDY, TO ASSESS THE EFFECT OF GED-0507-34-Levo 80 mg Tablets IN INDUCTION OF REMISSION OF ACTIVE ULCERATIVE COLITIS | |||||||||||||
Medical condition: Active Ulcerative Colitis Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-009602-10 | Sponsor Protocol Number: P070164 | Start Date*: 2009-09-18 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: MICIVAX : Essai randomisé contrôlé contre placebo évaluant l’efficacité et la tolérance de la vaccination anti-grippale chez des patients traités par immunosuppresseurs pour une Maladie Inflammatoi... | |||||||||||||
Medical condition: MICI | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014825-18 | Sponsor Protocol Number: P070165 | Start Date*: 2009-09-18 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Etude prospective multicentrique ouverte évaluant l'efficacité immunologique et la tolérance de la vaccination grippale chez des patients suivis pour une maladie inflammatoire chronique intestinale... | |||||||||||||
Medical condition: MICI | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000570-28 | Sponsor Protocol Number: IFX001PSHP | Start Date*: 2021-11-09 |
Sponsor Name:Tampere University Hospital | ||
Full Title: Accelerated infliximab infusions in inflammatory bowel disease, Phase IV trial | ||
Medical condition: Inflammatory bowel diseases | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012544-16 | Sponsor Protocol Number: P-Monofer-IBD-01 | Start Date*: 2009-12-31 | ||||||||||||||||
Sponsor Name:Pharmacosmos A/S | ||||||||||||||||||
Full Title: A phase III, randomized, comparative, open-label study of intravenous iron oligosaccharide (Monofer®) administered by infusions or repeated bolus injections in comparison with oral iron sulphate in... | ||||||||||||||||||
Medical condition: Inflammatory bowel disease subjects with iron deficiency anaemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) DK (Completed) AT (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000842-11 | Sponsor Protocol Number: 18-122 | Start Date*: 2007-10-15 |
Sponsor Name:Medical University of Graz | ||
Full Title: 99Tc labled Inliximab for evaluation of inflammatory activity in patients with inflammtory bowel disease (IBD) | ||
Medical condition: Inflammatory bowel disease Crohn´s disease Ulcerative colitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005903-25 | Sponsor Protocol Number: SC12267-4-2008 | Start Date*: 2009-01-08 | |||||||||||
Sponsor Name:4SC AG | |||||||||||||
Full Title: Exploratory, open-label study to demonstrate efficacy, safety and tolerability of SC12267 (35 mg) in patients with inflammatory bowel disease (Crohn’s disease and ulcerative colitis) | |||||||||||||
Medical condition: inflammatory bowel disease (Crohn’s disease and ulcerative colitis) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002324-17 | Sponsor Protocol Number: TARIF | Start Date*: 2018-09-05 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Thiamin against robust IBD fatigue - The effect of oral thiamin supplement in 4 weeks to patients with inflammatory bowel disease (IBD) in remission and chronic fatigue. A randomised placebo contro... | |||||||||||||
Medical condition: Inflammatory bowel disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003293-32 | Sponsor Protocol Number: Duski2015 | Start Date*: 2017-11-06 | ||||||||||||||||
Sponsor Name:Academic Medical Center | ||||||||||||||||||
Full Title: Multicentre, Randomised, Placebo-Controlled Trial of Mebeverine in Children with Irritable Bowel Syndrome (IBS) or Functional Abdominal Pain - not otherwise specified (FAP-NOS) | ||||||||||||||||||
Medical condition: Functional Gastrointestinal Disorders (Irritable Bowel Syndrome or Functional Abdominal Pain - not otherwise specified) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003418-18 | Sponsor Protocol Number: SMR2268/TheMIBSStudy | Start Date*: 2012-01-09 | |||||||||||
Sponsor Name:Sahlgrenska University Hospital | |||||||||||||
Full Title: A Randomised, Double Blind, Placebo Controlled, Multi-centre, Parallel Group, Interventional Study of Mesalazine (Asacol®) Treatment in IBS and the Evaluation of Rectal Inflammatory Status using th... | |||||||||||||
Medical condition: Irritable Bowel Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.